Antiretroviral Therapy Containing Raltegravir to Prevent Mother-to-Child Transmission of HIV in Infected Pregnant Women

We conducted a retrospective study in a general hospital in Buenos Aires, Argentina (2009-2015) aimed at evaluating outcomes in HIV-infected pregnant women (HIPW), who were prescribed raltegravir (RAL)-containing antiretroviral therapy (ART). A total of 239 HIPW were enrolled in our study; among the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cecchini, Diego M., Martinez, Marina G., Morganti, Laura M., Rodriguez, Claudia G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2017
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477474/
https://www.ncbi.nlm.nih.gov/pubmed/28663779
http://dx.doi.org/10.4081/idr.2017.7017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477474/
https://www.ncbi.nlm.nih.gov/pubmed/28663779
http://dx.doi.org/10.4081/idr.2017.7017

Ejemplares similares